Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12887-018-1200-1 http://scihub22266oqcxt.onion/10.1186/s12887-018-1200-1 C6038274!6038274 !29986673     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29986673 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       BMC+Pediatr 2018 ; 18 (1 ): 225 Nephropedia Template TP {{tp|p=29986673 |t=2018. The BabySeq project: implementing genomic sequencing in newborns |pdf=|usr=}}{{29986673 }} gab.com Text The BabySeq project: implementing genomic sequencing in newborns JO: BMC Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=29986673 #FOAvip BACKGROUND: The greatest opportunity for lifelong impact of genomic sequencing is during the newborn period. The "BabySeq Project" is a randomized trial that explores the medical, behavioral, and economic impacts of integrating genomic sequencing into the care of healthy and sick newborns. METHODS: Families of newborns are enrolled from Boston Children's Hospital and Brigham and Women's Hospital nurseries, and half are randomized to receive genomic sequencing and a report that includes monogenic disease variants, recessive carrier variants for childhood onset or actionable disorders, and pharmacogenomic variants. All families participate in a disclosure session, which includes the return of results for those in the sequencing arm. Outcomes are collected through review of medical records and surveys of parents and health care providers and include the rationale for choice of genes and variants to report; what genomic data adds to the medical management of sick and healthy babies; and the medical, behavioral, and economic impacts of integrating genomic sequencing into the care of healthy and sick newborns. DISCUSSION: The BabySeq Project will provide empirical data about the risks, benefits and costs of newborn genomic sequencing and will inform policy decisions related to universal genomic screening of newborns. TRIAL REGISTRATION: The study is registered in ClinicalTrials.gov Identifier: NCT02422511 . Registration date: 10 April 2015. Twit Text FOAVip The BabySeq project: implementing genomic sequencing in newborns ????BMC Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=29986673 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29986673 #FOAvip English Wikipedia <ref>{{Cite pmid|29986673 }}</ref> The BabySeq project: implementing genomic sequencing in newborns #MMPMID29986673 Holm IA ; Agrawal PB ; Ceyhan-Birsoy O ; Christensen KD ; Fayer S ; Frankel LA ; Genetti CA ; Krier JB ; LaMay RC ; Levy HL ; McGuire AL ; Parad RB ; Park PJ ; Pereira S ; Rehm HL ; Schwartz TS ; Waisbren SE ; Yu TW ; Green RC ; Beggs AH BMC Pediatr 2018[Jul]; 18 (1 ): 225 PMID29986673 show ga BACKGROUND: The greatest opportunity for lifelong impact of genomic sequencing is during the newborn period. The "BabySeq Project" is a randomized trial that explores the medical, behavioral, and economic impacts of integrating genomic sequencing into the care of healthy and sick newborns. METHODS: Families of newborns are enrolled from Boston Children's Hospital and Brigham and Women's Hospital nurseries, and half are randomized to receive genomic sequencing and a report that includes monogenic disease variants, recessive carrier variants for childhood onset or actionable disorders, and pharmacogenomic variants. All families participate in a disclosure session, which includes the return of results for those in the sequencing arm. Outcomes are collected through review of medical records and surveys of parents and health care providers and include the rationale for choice of genes and variants to report; what genomic data adds to the medical management of sick and healthy babies; and the medical, behavioral, and economic impacts of integrating genomic sequencing into the care of healthy and sick newborns. DISCUSSION: The BabySeq Project will provide empirical data about the risks, benefits and costs of newborn genomic sequencing and will inform policy decisions related to universal genomic screening of newborns. TRIAL REGISTRATION: The study is registered in ClinicalTrials.gov Identifier: NCT02422511 . Registration date: 10 April 2015. |*Exome Sequencing [MESH] |Family/psychology [MESH] |Genetic Counseling [MESH] |Genetic Predisposition to Disease/psychology [MESH] |Health Care Costs [MESH] |Humans [MESH] |Infant, Newborn [MESH] |Neonatal Screening/economics/*methods/psychology [MESH]The BabySeq project: implementing genomic sequencing in newborns (epmc).pdf DeepDyve Pubget Overpricing